1. The Past, present, and future of pancreatic cancer clinical trials;Matrisian,2016
2. Cancer statistics, 2020;Siegel;CA A Cancer J Clin,2020
3. Characteristics of 10-year survivors of pancreatic ductal adenocarcinoma;Paniccia;JAMA Surg,2015
4. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011
5. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017